- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04916483
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
Exploring the Effectiveness of Group Cognitive Stimulation Therapy on Cognitive Function, Depressive Symptoms, Social Function and Quality of Life in People With Schizophrenia: A Randomized Controlled Trial
Background: Cognitive dysfunction is the core defect of schizophrenia, which seriously affects the emotional, social functions and quality of life in people with schizophrenia.
Objective: The purpose of this study is to explore the efficacy of group cognitive stimulation therapy in cognitive function, depressive symptoms, social function, and quality of life in people with Schizophrenia.
Research method:This study used a single-blind randomized controlled trial design. Participants's Montreal Cognitive Assessment Scale (MoCA) score between 10-25 points are include. Chronic rehabilitation wards were randomly assigned to the experimental group and the conventional treatment group using blocking. The experimental group (EG) (n = 45) is receive 7 weeks, twice a week, 60 minutes each time of group cognitive stimulation therapy(GCST), the control group (CG) (n = 45) maintain usual care.
Expected results: GCST can improve cognitive function, depressive symptoms, social function and quality of life in people with schizophrenia.
연구 개요
상세 설명
Background: Cognitive dysfunction is the core defect of schizophrenia, which seriously affects the emotional and social functions of patients. Group cognitive stimulation therapy has been supported by research abroad to improve cognition and mood. Domestically, this group of people with schizophrenia will also face the above symptoms. Therefore, non-pharmacological therapy is among mental health personnel It is worth paying attention to and developing in the process of providing medical services.
Objective: The purpose of this study explores the efficacy of group cognitive stimulation therapy in cognitive function, depressive symptoms, social function and quality of life in people with Schizophrenia.
Research method: This study used a single-blind randomized controlled trial design to reduce it to people with schizophrenia.This study used a single-blind randomized controlled trial design. Participants's Montreal Cognitive Assessment Scale (MoCA) score between 10-25 points are include. Chronic rehabilitation wards were randomly assigned to the EG and the CG using blocking. The EG receive 7 weeks, twice a week, 60 minutes each time of GCST, the CG maintain usual care. Both groups use the Montreal Cognitive Assessment Scale (MoCA), the Taiwanese Version of Frontal Assessment Battery (TFAB), the Beck Depression Inventory II (Beck Depression Inventory II, BDI-II), and Social Function Scales-Taiwanese version(SFST) and WHOQOL-BREF is use as an evaluation tool to measure the results at the baseline, T1 (7th weeks) and T2 (20th weeks). The research results were filed and statistically analyzed with IBM SPSS 20.0 software package. Descriptive statistics were used for general demographic variables and primary , secondary outcome: mean, SD, range, percentage. The difference between the two groups of benchmark values was analyzed with t-test or χ2, independent-t test, pair-t, and GEE.
Expected results: GCST can improve cognitive function, depressive symptoms, social function and quality of life in people with schizophrenia.
연구 유형
등록 (예상)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Chia-Chi Chang, MSN
- 전화번호: 3317 886-3-211-8999
- 이메일: ccchang@mail.cgust.edu.tw
연구 연락처 백업
- 이름: Chiu-Yueh Yang, PhD
- 전화번호: 7388 886-2-2826
- 이메일: cyyang3@ym.edu.tw
연구 장소
-
-
-
Taipei City, 대만
- 모병
- National Yang-Ming Jiaotong University
-
연락하다:
- Yang Chiu Yueh, PhD
- 전화번호: 02-28267388
- 이메일: cyyang3@ym.edu.tw
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- People who according the DSM-5 diagnosis of schizophrenia spectrum and have been sick for more than two years.
- Age between 20 and 65 years old.
- There are currently rules for receiving antipsychotics treatment.
- Regardless of whether you take antidepressants or not.
- Can communicate clearly in Mandarin and Taiwanese.
- Those with a score of 10-25 on the Montreal Cognitive Assessment Scale (MoCA).
- Those who are willing to participate in this study and complete the subject consent form.
Exclusion Criteria:
- According to DSM-5 criteria, suspected bipolar disorder, anxiety disorder, obsessive- compulsive disorder, cognitive impairment, substance use disorders, and other unthinking disorders are exclusion.
- Have been in or out of the acute ward within three months and currently have suicidal attempts or violence.
- Those who are receiving individual or group cognitive behavior therapy.
- People with intellectual disabilities.
- Those who are unable to conduct research due to visual or hearing impairment.
- People who are accepting other clinical trials.
- Those who have no intention to participate in this study or are unable to complete the subject's consent form.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Exploring the effectiveness of GCST in people with schizophrenia.
The experimental group will receive a total of 14 sessions, twice a week group cognitive stimulation therapy for 7 weeks.
|
The experimental group will receive totally 7 weeks,14 sessions, twice a week, and 60 minute group cognitive stimulation therapy (GCST).
다른 이름들:
The control group maintains the unit routine treatment.
|
간섭 없음: Control group
The control group maintains the usual care.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Montreal Cognitive Assessment, MoCA
기간: baseline
|
Cognitive function test
|
baseline
|
Taiwanese Version of Frontal Assessment Battery, TFAB
기간: baseline
|
Cognitive function test
|
baseline
|
Wechsler Memory Scale-Third Edition, WMS-III
기간: baseline
|
Cognitive function test
|
baseline
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Beck Depression Inventory II, BDI-II
기간: baseline
|
Depressive symptoms test
|
baseline
|
Social Function Scales-Taiwanese version, SFST
기간: baseline
|
Social Function test
|
baseline
|
WHOQOL-BREF
기간: baseline
|
quality of life test
|
baseline
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Montreal Cognitive Assessment, MoCA
기간: 7th weeks
|
Cognitive function test
|
7th weeks
|
Taiwanese Version of Frontal Assessment Battery, TFAB
기간: 7th weeks
|
Cognitive function test
|
7th weeks
|
Wechsler Memory Scale-Third Edition, WMS-III
기간: 7th weeks
|
Cognitive function test
|
7th weeks
|
Beck Depression Inventory II, BDI-II
기간: 7th weeks
|
Depressive symptoms test
|
7th weeks
|
Social Function Scales-Taiwanese version, SFST
기간: 7th weeks
|
Social Function test
|
7th weeks
|
WHOQOL-BREF
기간: 7th weeks
|
quality of life test
|
7th weeks
|
Montreal Cognitive Assessment, MoCA
기간: 20th week
|
Cognitive function test
|
20th week
|
Taiwanese Version of Frontal Assessment Battery, TFAB
기간: 20th week
|
Cognitive function test
|
20th week
|
Wechsler Memory Scale-Third Edition, WMS-III
기간: 20th week
|
Wechsler Memory Scale-Third Edition, WMS-III
|
20th week
|
Beck Depression Inventory II, BDI-II
기간: 20th week
|
Depressive symptoms test
|
20th week
|
Social Function Scales-Taiwanese version, SFST
기간: 20th week
|
Social Function test
|
20th week
|
WHOQOL-BREF
기간: 20th week
|
quality of life test
|
20th week
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Chiu-Yueh Yang, PhD, National Yang-Ming Jiaotong University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
인지 치료에 대한 임상 시험
-
Vascular Center BerlinBVMed - The German Medical Technology Association; German Society for Angiology - Society...완전한PAD에서 효능/장기적 효과 Endovascular Therapy
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Cancer Hospital; West China Hospital; Third Affiliated Hospital, Sun Yat-Sen University 그리고 다른 협력자들모병간 종양 치료를 위한 Steep Pulse Therapy System중국
group cognitive stimulation therapy에 대한 임상 시험
-
Masaryk UniversityMasaryk Memorial Cancer Institute모병
-
Masaryk UniversityMasaryk Memorial Cancer Institute모병